Upgrade to SI Premium - Free Trial

Form 25-NSE Cascadian Therapeutics, Filed by: The Nasdaq Stock Market LLC

March 9, 2018 9:17 AM



    X0203

    
        0001354457
        The Nasdaq Stock Market LLC
    

    
        0001412067
        Cascadian Therapeutics, Inc.
        001-33882
        
2601 4th Avenue Suite 500 Seattle WA WASHINGTON 98121
206 801-2100
Common Stock 17 CFR 240.12d2-2(a)(3) Tara Petta Director 2018-03-09
casc-form25

Categories

SEC Filings